{"id":"https://openalex.org/W7015589844","doi":null,"title":"Synthesis and Evaluation of Atypical Psychoplastogens","display_name":"Synthesis and Evaluation of Atypical Psychoplastogens","alternate_titles":[],"publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W7015589844"},"language":"en","primary_location":{"id":"pmh:oai:escholarship.org:ark:/13030/qt8mx832t5","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/8mx832t5","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"etd"},"parent_works":[],"lineage":["https://openalex.org/W7015589844"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060658856","display_name":"Hunter T. Warren","orcid":"https://orcid.org/0000-0002-6195-6722","observed_orcids":["https://orcid.org/0000-0002-6195-6722"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Warren, Hunter Thomas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5060658856"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5346999764442444,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5346999764442444,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.385699987411499,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.01549999974668026,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psychoplastogens","display_name":"psychoplastogens","score":1.0},{"id":"https://openalex.org/keywords/neuronal-atrophy","display_name":"neuronal atrophy","score":0.8930000066757202},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.9359999895095825},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9789999723434448},{"id":"https://openalex.org/keywords/tropane-alkaloids","display_name":"tropane alkaloids","score":0.7440000176429749},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6710000038146973},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/rational-drug-design","display_name":"rational drug design","score":0.7799999713897705},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.921999990940094},{"id":"https://openalex.org/keywords/off-target-interactions","display_name":"off-target interactions","score":0.7979999780654907},{"id":"https://openalex.org/keywords/mood-disorders","display_name":"mood disorders","score":0.8410000205039978},{"id":"https://openalex.org/keywords/neurotherapeutics","display_name":"neurotherapeutics","score":0.6890000104904175}],"concepts":[{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.7734000086784363},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.5965999960899353},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4837999939918518},{"id":"https://openalex.org/C2776995303","wikidata":"https://www.wikidata.org/wiki/Q410271","display_name":"Tropane","level":2,"score":0.43799999356269836},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4291999936103821},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41130000352859497},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3864000141620636},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3601999878883362},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3490000069141388},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3246999979019165},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.3111000061035156},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.29319998621940613},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.28600001335144043},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2791999876499176},{"id":"https://openalex.org/C107459253","wikidata":"https://www.wikidata.org/wiki/Q674925","display_name":"Induced pluripotent stem cell","level":4,"score":0.27459999918937683},{"id":"https://openalex.org/C3019038264","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug candidate","level":3,"score":0.27140000462532043},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.2506999969482422}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:escholarship.org:ark:/13030/qt8mx832t5","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/8mx832t5","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"etd"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6996808351","https://openalex.org/W3086471578","https://openalex.org/W4385666098","https://openalex.org/W6990388389","https://openalex.org/W4394996482","https://openalex.org/W2892307734","https://openalex.org/W4414180277","https://openalex.org/W4409415903","https://openalex.org/W3204230901","https://openalex.org/W3002940062"],"abstract_inverted_index":{"Neuronal":[0],"atrophy":[1],"is":[2],"an":[3],"underlying":[4],"characteristic":[5],"of":[6,17,35,38,42,53,79,99,103,105,112,124,172,176,194],"neurodegenerative":[7],"diseases":[8],"and":[9,73,88,126,156],"many":[10],"mood":[11],"disorders.":[12],"Considering":[13],"that":[14,119],"the":[15,51,90,97,110,138,180],"prevalence":[16],"these":[18],"conditions":[19],"has":[20],"only":[21],"continued":[22],"to":[23,61,66,74,147,168,197],"rise":[24],"in":[25,109,143],"recent":[26],"decades,":[27],"efficacious":[28],"treatments":[29],"are":[30,185],"desperately":[31],"needed.":[32],"The":[33],"discovery":[34],"psychoplastogens\u2014a":[36],"class":[37],"small":[39],"molecules":[40],"capable":[41,171],"rapidly":[43],"promoting":[44],"neuronal":[45,198],"growth\u2014has":[46],"provided":[47],"a":[48,106,117,132,165,186,192],"foundation":[49],"for":[50,92,159,191],"development":[52],"improved":[54,153,189],"neurotherapeutics.":[55],"My":[56],"research":[57],"objectives":[58],"have":[59],"been":[60],"utilize":[62],"rational":[63],"drug":[64],"design":[65,169],"create":[67],"psychoplastogens":[68,81,100,182],"with":[69,101,152],"novel":[70,149],"pharmacological":[71],"profiles,":[72],"mitigate":[75],"potential":[76,91,158],"safety":[77,154],"concerns":[78],"known":[80],"by":[82],"engineering":[83],"out":[84],"unwanted":[85],"off-target":[86],"interactions":[87],"mitigating":[89],"side":[93,160],"effects.":[94,161],"By":[95],"combining":[96],"pharmacophores":[98],"those":[102],"inhibitors":[104],"kinase":[107],"implicated":[108],"pathophysiology":[111],"neurogenerative":[113],"diseases,":[114],"I":[115,130,163],"created":[116],"psychoplastogen":[118],"can":[120],"address":[121],"multiple":[122],"hallmarks":[123],"Alzheimer\u2019s":[125],"related":[127,196],"diseases.":[128],"Additionally,":[129],"conducted":[131],"structure\u2013activity":[133],"relationship":[134],"study":[135],"centered":[136],"around":[137],"tropane":[139,145],"core":[140],"structure":[141],"present":[142],"psychoplastogenic":[144,150],"alkaloids":[146],"discover":[148],"tropanes":[151],"profiles":[155],"mitigated":[157],"Finally,":[162],"utilized":[164],"prodrug":[166],"approach":[167],"compounds":[170],"increasing":[173],"endogenous":[174],"levels":[175],"psychoplastogens.":[177],"All":[178],"told,":[179],"atypical":[181],"described":[183],"herein":[184],"step":[187],"towards":[188],"therapeutics":[190],"number":[193],"disorders":[195],"atrophy.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7015589844","counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2025-10-10T00:00:00"}
